Perkins Coie Trust Company’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
1,326
-1,423
-52% -$211K 0.04% 96
2026
Q1
$256K Hold
2,749
0.05% 93
2025
Q4
$221K Hold
2,749
0.04% 104
2025
Q3
$268K Hold
2,749
0.05% 90
2025
Q2
$192K Buy
2,749
+74
+3% +$4.22K 0.03% 114
2025
Q1
$133K Buy
2,675
+225
+9% +$14.2K 0.03% 131
2024
Q4
$171K Hold
2,450
0.04% 116
2024
Q3
$257K Buy
2,450
+700
+40% +$81.9K 0.06% 96
2024
Q2
$249K Buy
+1,750
New +$202K 0.06% 93

Other funds holding ACLS

Perkins Coie Trust Company's ACLS Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its Axcelis (ACLS) stake by 52% in Q2 2026, selling an estimated $211K and leaving 1,326 shares worth $251K. The position accounts for 0.04% of the portfolio, ranked #96.

Perkins Coie Trust Company first reported a position in ACLS in Q2 2024 and has held it in 9 quarters since. The position peaked at $268K in Q3 2025. 52 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Perkins Coie Trust Company held 1,326 shares of Axcelis worth $251K as of Q2 2026.
  • Perkins Coie Trust Company sold 1,423 Axcelis shares in Q2 2026, an estimated $211K.
  • Axcelis made up 0.04% of Perkins Coie Trust Company's portfolio in Q2 2026, its #96 holding.
  • Perkins Coie Trust Company first reported a position in Axcelis in Q2 2024 and has held it in 9 quarters since.
  • Perkins Coie Trust Company's Axcelis position peaked at $268K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.